Home | News | Directories | Calendar | Maps | Contact Us | Webmail
Perelman School of Medicine at the University of Pennsylvania Advanced Search

Kenneth S. Shindler, M.D., Ph.D.

Kenneth S. Shindler, M.D., Ph.D.

faculty photo
Assistant Professor of Ophthalmology
Department: Ophthalmology
Graduate Group Affiliations

Contact information
Scheie Eye Institute
51 North 39th Street
Philadelphia, PA 19104
Education:
ScB (Biochemistry)
Brown University, Providence, 1991.
MD, PhD (Medicine/Neuroscience)
Washington University, St. Louis, 1999.
Permanent link
 
Perelman School of Medicine > Faculty > Search

Description of Research Expertise

Dr. Shindler's research is examing potential mechanisms to provide neuroprotection of retinal ganglion cells in optic neuritis. Optic neuritis is an inflammatory disease of the optic nerve that often occurs as part of the neurodegenerative disease multiple sclerosis. Damage to nerve cells can lead to permanent vision loss in these patients. Dr. Shindler's studies are helping to identify new therapies to prevent nerve damage in this disease, and such therapies will also likely have benefits for other neurodegenerative diseases as well.

Keywords
Neuro-ophthalmologic conditions, including optic neuropathies, papilledema, and binocular double vision

Description of Clinical Expertise

Neuro-ophthalmology. Dr. Shindler treats patients with neuro-ophthalmologic conditions, including optic neuropathies, papilledema, and binocular double vision.

Selected Publications

Khan RS, Dine K, Das Sarma J, Shindler KS : SIRT1 activating compounds reduce oxidative stress mediated neuronal loss in viral induced CNS demyelinating disease Acta Neuropathol. Commun. 2(1): 3, Jan 2014.

Zuo L, Khan RS, Lee V, Dine K, Wu W, Shindler KS: SIRT1 promotes RGC survival and delays loss of function following optic nerve crush. Invest. Ophthalmol. Vis. Sci. 54(7): 5097-102, Jul 2013.

Chen Y, Khan RS, Cwanger A, Song Y, Steenstra C, Bang S, Cheah JH, Dunaief J, Shindler KS, Snyder SH, Kim SF: Dexras1, a small GTPase, is required for glutamate-NMDA neurotoxicity J. Neurosci. 33(8): 3582-7, Feb 2013.

Khan RS, Fonseca-Kelly Z, Callinan C, Zuo L, Sachdeva MM, Shindler KS: SIRT1 activating compounds reduce oxidative stress and prevent cell death in neuronal cells. Front. Cell. Neurosci. 6: 63, Dec 2012.

Fonseca-Kelly Z, Nassrallah M, Uribe J, Khan RS, Dine K,Dutt M, Shindler KS: Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis. Front. Neurol. 3: 84, May 2012.

Quinn T, Dutt M, Shindler KS: Optic neuritis and retinal ganglion cell loss in a chronic murine model of multiple sclerosis. Front. Neurol. 2: 50, Aug 2011.

Shindler KS, Chatterjee D, Biswas K, GoyalA, DuttM, Nassrallah M, Khan RS, Das Sarma J: Macrophage-mediated optic neuritis induced by retrograde axonal transport of spike gene recombinant mouse hepatitis virus. J. Neuropathol. Exp. Neurol. 70(6): 470-80, June 2011.

Shindler KS, Ventura E, Dutt M, Elliott P, Fitzgerald DC, Rostami A: Oral resveratrol reduces neuronal damage in a model of multiple sclerosis. J. of Neuro-Ophthalmol. 30(4): 328-39, Dec 2010.

Das Sarma J, Kenyon LC, Hingley ST, Shindler KS: Mechanisms of primary axonal damage in a viral model of multiple sclerosis J. Neurosci. 29(33): 10272-10280, Aug 2009.

Shindler KS, Ventura E, Rex, TS, Elliott P, Rostami A: SIRT1 activation confers neuroprotection in experimental optic neuritis. Invest. Ophthalmol. Vis. Sci. 48(8): 3602-3609, August 2007.

back to top
Last updated: 12/16/2014
The Trustees of the University of Pennsylvania